19 results
424B4
WINT
Windtree Therapeutics, Inc.
20 Apr 23
Prospectus supplement with pricing info
6:03pm
, reputational harm, diminished profits and future earnings, additional reporting requirements and oversight if we become subject to a corporate integrity
424B4
mz6tbrmju7 i5glml
21 May 20
Prospectus supplement with pricing info
6:04am
- Prev
- 1
- Next